Screening for depression in a diabetic outpatient population

Ella J. Daly, Madhukar H Trivedi, Philip Raskin, Bruce G. Grannemann

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Depression occurs twice as often in patients with diabetes and is associated with reduced compliance with exercise, diet, and medications. It is also associated with hyperglycemia and increased diabetic complications. Despite evidence that successful treatment is associated with improved glycemic control, many cases of depression are left untreated. Objectives. (1) Evaluate a combination screening strategy in an outpatient population; and (2) explore the association between glycemic control and depressive symptomatology. Methods. Ninety-two patients completed the Patient Health Questionnaire (PHQ-2). Patients with a PHQ-2 score ≥ 1 completed the 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR16). Using the QIDS-SR16, a score of ≤5 corresponded to normal mood, with scores above 5 corresponding to increasing severity of depressive symptoms. Glycemic control was assessed by glycosylated hemoglobin (HbA1c). Results. Using a PHQ-2 cut-off score of ≥3, 37% of the sample screened positive for major depressive disorder (MDD), with an additional 27% reporting sub-threshold symptoms. The depressed group reported significantly more difficulty with reduced interests, insomnia, concentration, self-criticism, energy/fatigue and depressed mood. In terms of glycemic control, there was a marginally significant effect for race and HbA1c. Conclusion. The combined PHQ-2 and QIDS-SR16 can facilitate prompt detection of MDD and provide a means of monitoring specific symptoms and progress once treatment commences.

Original languageEnglish (US)
Pages (from-to)268-272
Number of pages5
JournalInternational Journal of Psychiatry in Clinical Practice
Volume11
Issue number4
DOIs
StatePublished - 2007

Fingerprint

Outpatients
Depression
Major Depressive Disorder
Population
Glycosylated Hemoglobin A
Sleep Initiation and Maintenance Disorders
Diabetes Complications
Hyperglycemia
Fatigue
Exercise
Diet
Equipment and Supplies
Health
Therapeutics

Keywords

  • Depression
  • Diabetes
  • Screening

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Screening for depression in a diabetic outpatient population. / Daly, Ella J.; Trivedi, Madhukar H; Raskin, Philip; Grannemann, Bruce G.

In: International Journal of Psychiatry in Clinical Practice, Vol. 11, No. 4, 2007, p. 268-272.

Research output: Contribution to journalArticle

@article{b30c6a5830a140c1a3c11968de1e12e9,
title = "Screening for depression in a diabetic outpatient population",
abstract = "Depression occurs twice as often in patients with diabetes and is associated with reduced compliance with exercise, diet, and medications. It is also associated with hyperglycemia and increased diabetic complications. Despite evidence that successful treatment is associated with improved glycemic control, many cases of depression are left untreated. Objectives. (1) Evaluate a combination screening strategy in an outpatient population; and (2) explore the association between glycemic control and depressive symptomatology. Methods. Ninety-two patients completed the Patient Health Questionnaire (PHQ-2). Patients with a PHQ-2 score ≥ 1 completed the 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR16). Using the QIDS-SR16, a score of ≤5 corresponded to normal mood, with scores above 5 corresponding to increasing severity of depressive symptoms. Glycemic control was assessed by glycosylated hemoglobin (HbA1c). Results. Using a PHQ-2 cut-off score of ≥3, 37{\%} of the sample screened positive for major depressive disorder (MDD), with an additional 27{\%} reporting sub-threshold symptoms. The depressed group reported significantly more difficulty with reduced interests, insomnia, concentration, self-criticism, energy/fatigue and depressed mood. In terms of glycemic control, there was a marginally significant effect for race and HbA1c. Conclusion. The combined PHQ-2 and QIDS-SR16 can facilitate prompt detection of MDD and provide a means of monitoring specific symptoms and progress once treatment commences.",
keywords = "Depression, Diabetes, Screening",
author = "Daly, {Ella J.} and Trivedi, {Madhukar H} and Philip Raskin and Grannemann, {Bruce G.}",
year = "2007",
doi = "10.1080/13651500701245981",
language = "English (US)",
volume = "11",
pages = "268--272",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Screening for depression in a diabetic outpatient population

AU - Daly, Ella J.

AU - Trivedi, Madhukar H

AU - Raskin, Philip

AU - Grannemann, Bruce G.

PY - 2007

Y1 - 2007

N2 - Depression occurs twice as often in patients with diabetes and is associated with reduced compliance with exercise, diet, and medications. It is also associated with hyperglycemia and increased diabetic complications. Despite evidence that successful treatment is associated with improved glycemic control, many cases of depression are left untreated. Objectives. (1) Evaluate a combination screening strategy in an outpatient population; and (2) explore the association between glycemic control and depressive symptomatology. Methods. Ninety-two patients completed the Patient Health Questionnaire (PHQ-2). Patients with a PHQ-2 score ≥ 1 completed the 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR16). Using the QIDS-SR16, a score of ≤5 corresponded to normal mood, with scores above 5 corresponding to increasing severity of depressive symptoms. Glycemic control was assessed by glycosylated hemoglobin (HbA1c). Results. Using a PHQ-2 cut-off score of ≥3, 37% of the sample screened positive for major depressive disorder (MDD), with an additional 27% reporting sub-threshold symptoms. The depressed group reported significantly more difficulty with reduced interests, insomnia, concentration, self-criticism, energy/fatigue and depressed mood. In terms of glycemic control, there was a marginally significant effect for race and HbA1c. Conclusion. The combined PHQ-2 and QIDS-SR16 can facilitate prompt detection of MDD and provide a means of monitoring specific symptoms and progress once treatment commences.

AB - Depression occurs twice as often in patients with diabetes and is associated with reduced compliance with exercise, diet, and medications. It is also associated with hyperglycemia and increased diabetic complications. Despite evidence that successful treatment is associated with improved glycemic control, many cases of depression are left untreated. Objectives. (1) Evaluate a combination screening strategy in an outpatient population; and (2) explore the association between glycemic control and depressive symptomatology. Methods. Ninety-two patients completed the Patient Health Questionnaire (PHQ-2). Patients with a PHQ-2 score ≥ 1 completed the 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR16). Using the QIDS-SR16, a score of ≤5 corresponded to normal mood, with scores above 5 corresponding to increasing severity of depressive symptoms. Glycemic control was assessed by glycosylated hemoglobin (HbA1c). Results. Using a PHQ-2 cut-off score of ≥3, 37% of the sample screened positive for major depressive disorder (MDD), with an additional 27% reporting sub-threshold symptoms. The depressed group reported significantly more difficulty with reduced interests, insomnia, concentration, self-criticism, energy/fatigue and depressed mood. In terms of glycemic control, there was a marginally significant effect for race and HbA1c. Conclusion. The combined PHQ-2 and QIDS-SR16 can facilitate prompt detection of MDD and provide a means of monitoring specific symptoms and progress once treatment commences.

KW - Depression

KW - Diabetes

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=36249006072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36249006072&partnerID=8YFLogxK

U2 - 10.1080/13651500701245981

DO - 10.1080/13651500701245981

M3 - Article

C2 - 24940725

AN - SCOPUS:36249006072

VL - 11

SP - 268

EP - 272

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 4

ER -